Skip Navigation

European Journal of Heart Failure 2000 2(3):287-289; doi:10.1016/S1388-9842(00)00092-1
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (10)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Owen, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Owen, A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2000 European Society of Cardiology

Experience of commencing Carvedilol in elderly patients with heart failure in a routine outpatient clinic

Andrew Owen*

Department of Cardiology, Kent & Canterbury Hospital Ethelbert Road, Canterbury, Kent CT1 3LP, UK


   Abstract

Carvedilol has been shown to be beneficial for patients with heart failure, but it is not clear how it should be initiated in routine clinical practice, particularly in the elderly. This study is a retrospective review of 19 patients of age 80±4 years with heart failure, who had Carvedilol treatment initiated in a routine outpatient clinic. No patient experienced a worsening of their heart failure or required admission to hospital. There was a mean reduction in heart rate of 11 beats/min. Carvedilol was tolerated by 68% of the patients. Thus, Carvedilol can be safely initiated in a routine outpatient clinic in appropriately selected elderly patients.

Key Words: Heart failure • Elderly • Carvedilol • Outpatient

Received December 15, 1999; Revised March 20, 2000; Accepted May 23, 2000


* Tel.: +44-01227-766877 (ext. 3031); fax: +44-01227-781306.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Eur J Heart FailHome page
F. Gustafsson, M. Schou, L. Videbaek, T. Nielsen, H. Ulriksen, J. Markenvard, T. L. Svendsen, H. Ryde, E. Vigholt, P. Hildebrandt, et al.
Treatment with beta-blockers in nurse-led heart failure clinics: Titration efficacy and predictors of failure
Eur J Heart Fail, September 1, 2007; 9(9): 910 - 916.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
M. H. Farrell, J. M. Foody, and H. M. Krumholz
{beta}-Blockers in Heart Failure: Clinical Applications
JAMA, February 20, 2002; 287(7): 890 - 897.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.